First results of the DEB-AMI (Drug Eluting Balloon in Acute ST-segment elevation myocardial infarction) Trial: A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes

Journal of the American College of Cardiology

Volumn 59, Issue 25, 2012, Pages 2327-2337

  Belkacemi, Anouar ^a   Agostoni, Pierfrancesco ^a   Nathoe, Hendrik M ^a   Voskuil, Michiel ^a   Shao, Chunlai ^a   Van Belle, Eric ^a   Wildbergh, Thierry ^a   Politi, Luigi ^b   Doevendans, Pieter A ^a   Sangiorgi, Giuseppe M ^b   Stella, Pieter R ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

angioplasty; drug eluting balloon; myocardial infarction; STEMI; stent

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; GLYCERYL TRINITRATE; HEPARIN; PACLITAXEL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; BLOOD CLOT LYSIS; BLOOD CLOTTING TIME; CARDIAC IMAGING; CARDIOGENIC SHOCK; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ELUTING STENT; ELECTROCARDIOGRAPHY; ENDOTHELIUM; FEMALE; HUMAN; IN-STENT RESTENOSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; SINGLE BLIND PROCEDURE; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; THROMBUS ASPIRATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; CHROMIUM; COBALT; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; SINGLE-BLIND METHOD; STENTS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 84862171761     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.02.027     Document Type: Article

References (24)

1. G.W. Stone, B. Witzenbichler, G. Guagliumi Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial Lancet 377 2011 2193 2204
2. G.W. Stone, H. Parise, B. Witzenbichler Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up: 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial J Am Coll Cardiol 56 2010 1597 1604
3. M.A. Vink, M.T. Dirksen, M.J. Suttorp 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial J Am Coll Cardiol Intv 4 2011 24 29
4. G. Nakazawa, A.V. Finn, M. Joner Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study Circulation 118 2008 1138 1145
5. G. Guagliumi, M.A. Costa, V. Sirbu Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial Circulation 123 2011 274 281
6. T. Nakamura, B.C. Brott, I. Brants Vasomotor function after paclitaxel-coated balloon post-dilation in porcine coronary stent model J Am Coll Cardiol Intv 4 2011 247 255
7. B.C. Brott, A.S. Anayiotos, G.D. Chapman, P.G. Anderson, W.B. Hillegass Severe, diffuse coronary artery spasm after drug-eluting stent placement J Invasive Cardiol 18 2006 584 592 (Pubitemid 46088082)
8. P.R. Stella, A. Belkacemi, R. Waksman The Valentines trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment EuroIntervention 7 2011 705 710
9. P.R. Stella, A. Belkacemi, P. Agostoni Drug-eluting balloons and bifurcations, a new future? EuroIntervention 6 Suppl J 2010 J161 J164
10. M. Unverdorben, C. Vallbracht, B. Cremers Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis Circulation 119 2009 2986 2994
11. B. Scheller, C. Hehrlein, W. Bocksch Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter Clin Res Cardiol 97 2008 773 781
12. A. Posa, N. Nyolczas, R. Hemetsberger Optimization of drug-eluting balloon use for safety and efficacy: evaluation of the 2nd generation paclitaxel-eluting DIOR-balloon in porcine coronary arteries Catheter Cardiovasc Interv 76 2010 395 403
13. K.K. Kuiper, M. Salem, S. Rotevatn, J. Mills, J.E. Nordrehaug Implementing a best-treatment strategy with intracoronary brachytherapy for in-stent restenosis in patients at high risk for recurrence Cardiovasc Revasc Med 8 2007 9 14 (Pubitemid 46216176)
14. D.E. Cutlip, S. Windecker, R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
15. P. Garrone, G. Biondi-Zoccai, I. Salvetti Quantitative coronary angiography in the current era: principles and applications J Interv Cardiol 22 2009 527 536
16. F. Prati, M. Cera, V. Ramazzotti From bench to bedside: a novel technique of acquiring OCT images Circ J 72 2008 839 843 (Pubitemid 351716692)
17. E.A. Mehanna, G.F. Attizzani, H. Kyono, M. Hake, H.G. Bezerra Assessment of coronary stent by optical coherence tomography, methodology and definitions Int J Cardiovasc Imaging 27 2010 259 269
18. J. Tanigawa, P. Barlis, K. Dimopoulos, C. Di Mario Optical coherence tomography to assess malapposition in overlapping drug-eluting stents EuroIntervention 3 2008 580 583
19. D.I. Axel, W. Kunert, C. Goggelmann Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery Circulation 96 1997 636 645 (Pubitemid 27329445)
20. B. Vaquerizo, A. Serra, F. Miranda-Guardiola One-year outcomes with angiographic follow-up of paclitaxel-eluting balloon for the treatment of in-stent restenosis: insights from Spanish Multicenter Registry J Interv Cardiol 6 2011 518 528
21. A.V. Finn, G. Nakazawa, M. Joner Vascular responses to drug eluting stents: importance of delayed healing Arterioscler Thromb Vasc Biol 27 2007 1500 1510 (Pubitemid 46986103)
22. M. Joner, A.V. Finn, A. Farb Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202 (Pubitemid 43929240)
23. P.R. Stella, A. Belkacemi, C. Dubois A multicenter randomized comparison of drug-eluting balloon plus bare metal stent versus bare metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the DEBIUT (Drug Eluting Balloon In BIfUrcations) trial Catheter Cardiovasc Interv 2012 Mar 15 [E-pub ahead of print]
24. P.W. Radke, M. Joner, A. Joost Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients EuroIntervention 7 2011 730 737